from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1018c/glmU

LFCtreatmentdescriptionclass of inhibitor

-0.547

Amikacinug/mL Amikacintranslation

0.073

Cap5-10ug/mL Capreomycintranslation

0.399

Rox10-50 ug/mL Roxithromycintranslation

0.537

SM2-5 ug/mL Streptomycintranslation

0.016

Tet5-10 ug/mL Tetracyclinetranslation

-0.637

Rif0.2-5ug/mL Rifampicintranscription

0.112

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.971

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.451

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-1.004

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.419

Clofazimine10-13 ug/mL Clofaziminerespiration

0.596

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.340

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.785

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.913

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.620

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.163

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.771

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.084

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.297

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.301

KCN5-20 ug/mL Potassium cyaniderespiration

-0.742

NaN30.2-2 mM Sodium aziderespiration

0.930

Nigericin50 uM Nigericinrespiration

-0.786

TRC10-150 ug/mL Triclosanrespiration

-1.026

TRZ10-25 ug/mL Thioridazinerespiration

-2.507

Valinomycin0.5-10 uM Valinomycinrespiration

1.198

ZnSO42 mM ZnSO4respiration

-0.130

menadione6-10 ug/mL Menadionerespiration

-0.177

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.452

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.163

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.774

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.928

NRP_1Non-replicating persistence stage 1dosRassociated

0.914

Amp0.2mg/mL AmpicillincellWall

0.298

Cephalexin20-100 ug/mL CephalexincellWall

0.725

Cerulenin0.32-5 ug/mL CerulenincellWall

0.363

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.187

EMB10-20 ug/mL EthambutolcellWall

0.380

Eta12-40 ug/mL EthionamidecellWall

-0.084

INH0.2-0.4 ug/mL IsoniazidcellWall

0.365

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.314

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.791

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.024

BZA0.12 mg/mL BenzamidearomaticAmides

0.193

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.458

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.303

H2O24 mM hydrogen peroxideDNAdamaging

0.256

Levo10 ug/mL LevofloxacinDNAdamaging

0.896

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.672

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.190

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.668

UVUV-irradiationDNAdamaging

-1.887

ARP41-4 ug/mL Antitubercular compound ARP4?

0.441

Antimycin12.5-50 ug/mL Antimycin A?

0.538

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.208

PA_110-50 ug/mL Antitubercular compound PA-1?

0.288

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.376

PA8240.2-2 ug/mL PA-824?

-1.582

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.878

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.519

Verapamil50 uM Verapamil?

0.204

mercaptoethanol2 mM 2-Mercaptoethanol?

0.884

methoxatin10-20 ug/mL Methoxatin?